These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17471843)

  • 1. [Antiendothelial cell antibodies as a risk factor of atherosclerosis in systemic lupus erythematosus].
    Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M
    Ann Acad Med Stetin; 2006; 52 Suppl 2():95-9. PubMed ID: 17471843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
    Fischer K
    Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
    Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M
    Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus.
    Falaschi F; Ravelli A; Martignoni A; Migliavacca D; Sartori M; Pistorio A; Perani G; Martini A
    Arthritis Rheum; 2000 Jun; 43(6):1405-9. PubMed ID: 10857801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus.
    Yoshio T; Masuyama J; Sumiya M; Minota S; Kano S
    J Rheumatol; 1994 Nov; 21(11):2058-63. PubMed ID: 7869310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased binding of annexin v to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus.
    Cederholm A; Svenungsson E; Jensen-Urstad K; Trollmo C; Ulfgren AK; Swedenborg J; Fei GZ; Frostegård J
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):198-203. PubMed ID: 15539620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus.
    Doria A; Shoenfeld Y; Wu R; Gambari PF; Puato M; Ghirardello A; Gilburd B; Corbanese S; Patnaik M; Zampieri S; Peter JB; Favaretto E; Iaccarino L; Sherer Y; Todesco S; Pauletto P
    Ann Rheum Dis; 2003 Nov; 62(11):1071-7. PubMed ID: 14583570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carotid subclinical atherosclerosis is associated with disease activity but not vitamin D in Korean systemic lupus erythematosus.
    Jung JY; Koh BR; Bae CB; Kim HA; Suh CH
    Lupus; 2014 Dec; 23(14):1517-22. PubMed ID: 25059488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study).
    Colombo BM; Cacciapaglia F; Puntoni M; Murdaca G; Rossi E; Rodriguez G; Nobili F; Pisciotta L; Bertolini S; Moccetti T; Dentali F; Steidl L; Ciprandi G; Afeltra A; Indiveri F; Puppo F
    Autoimmun Rev; 2009 Feb; 8(4):309-15. PubMed ID: 18976721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus.
    Cederholm A; Svenungsson E; Stengel D; Fei GZ; Pockley AG; Ninio E; Frostegård J
    Arthritis Rheum; 2004 Sep; 50(9):2869-76. PubMed ID: 15457454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus.
    de Leeuw K; Smit AJ; de Groot E; van Roon AM; Kallenberg CG; Bijl M
    Atherosclerosis; 2009 Oct; 206(2):546-50. PubMed ID: 19389674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced carotid intima-media thickness in systemic lupus erythematosus patients treated with cyclosporine A.
    Oryoji K; Kiyohara C; Horiuchi T; Tsukamoto H; Niiro H; Shimoda T; Akashi K; Yanase T
    Mod Rheumatol; 2014 Jan; 24(1):86-92. PubMed ID: 24261763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response.
    Conti F; Spinelli FR; Alessandri C; Pacelli M; Ceccarelli F; Marocchi E; Montali A; Capozzi A; Buttari B; Profumo E; Sorice M; Arca M; Valesini G; Riganò R
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):661-8. PubMed ID: 24436371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated backscatter analysis of carotid intima-media complex in patients with systemic lupus erythematosus.
    Rossi M; Mosca M; Tani C; Franzoni F; Santoro G; Bombardieri S
    Clin Rheumatol; 2008 Dec; 27(12):1485-8. PubMed ID: 18654734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Levels of Anti-PON1 and Anti-HDL Antibodies as Potential Biomarkers of Premature Atherosclerosis in Systemic Lupus Erythematosus.
    López P; Rodríguez-Carrio J; Martínez-Zapico A; Pérez-Álvarez ÁI; López-Mejías R; Benavente L; Mozo L; Caminal-Montero L; González-Gay MA; Suárez A
    Thromb Haemost; 2017 Nov; 117(11):2194-2206. PubMed ID: 29044294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural immune response involving anti-endothelial cell antibodies in normal and lupus pregnancy.
    Mendonca LL; Khamashta MA; Cuadrado MJ; Bertolaccini ML; Hughes GR
    Arthritis Rheum; 2000 Jul; 43(7):1511-5. PubMed ID: 10902753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-endothelial cell antibodies in patients with systemic lupus erythematosus.
    Liu MF; Lei HY
    J Formos Med Assoc; 1991 Mar; 90(3):221-4. PubMed ID: 1677395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women.
    El-Magadmi M; Bodill H; Ahmad Y; Durrington PN; Mackness M; Walker M; Bernstein RM; Bruce IN
    Circulation; 2004 Jul; 110(4):399-404. PubMed ID: 15262847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner.
    Carvalho D; Savage CO; Isenberg D; Pearson JD
    Arthritis Rheum; 1999 Apr; 42(4):631-40. PubMed ID: 10211876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.